JP2009503021A5 - - Google Patents

Download PDF

Info

Publication number
JP2009503021A5
JP2009503021A5 JP2008524502A JP2008524502A JP2009503021A5 JP 2009503021 A5 JP2009503021 A5 JP 2009503021A5 JP 2008524502 A JP2008524502 A JP 2008524502A JP 2008524502 A JP2008524502 A JP 2008524502A JP 2009503021 A5 JP2009503021 A5 JP 2009503021A5
Authority
JP
Japan
Prior art keywords
alkyl
use according
halo
hydrogen
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008524502A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009503021A (ja
JP5208739B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/064847 external-priority patent/WO2007014934A2/en
Publication of JP2009503021A publication Critical patent/JP2009503021A/ja
Publication of JP2009503021A5 publication Critical patent/JP2009503021A5/ja
Application granted granted Critical
Publication of JP5208739B2 publication Critical patent/JP5208739B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008524502A 2005-08-03 2006-07-31 抗菌剤としてのキノリン誘導体 Expired - Fee Related JP5208739B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05107155.3 2005-08-03
EP05107155 2005-08-03
PCT/EP2006/064847 WO2007014934A2 (en) 2005-08-03 2006-07-31 Quinoline derivatives as antibacterial agents

Publications (3)

Publication Number Publication Date
JP2009503021A JP2009503021A (ja) 2009-01-29
JP2009503021A5 true JP2009503021A5 (enExample) 2009-09-17
JP5208739B2 JP5208739B2 (ja) 2013-06-12

Family

ID=35768115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008524502A Expired - Fee Related JP5208739B2 (ja) 2005-08-03 2006-07-31 抗菌剤としてのキノリン誘導体

Country Status (30)

Country Link
US (1) US8691800B2 (enExample)
EP (1) EP1912649B1 (enExample)
JP (1) JP5208739B2 (enExample)
KR (1) KR101413094B1 (enExample)
CN (1) CN101277698B (enExample)
AP (1) AP2483A (enExample)
AR (1) AR054888A1 (enExample)
AU (1) AU2006274873B2 (enExample)
BR (1) BRPI0614099B8 (enExample)
CA (1) CA2615900C (enExample)
CY (1) CY1113535T1 (enExample)
DK (1) DK1912649T3 (enExample)
EA (1) EA014834B1 (enExample)
ES (1) ES2397358T3 (enExample)
HR (1) HRP20120910T1 (enExample)
IL (1) IL189140A (enExample)
JO (1) JO2837B1 (enExample)
ME (1) ME01485B (enExample)
MX (1) MX2008001601A (enExample)
MY (1) MY147637A (enExample)
NO (1) NO342328B1 (enExample)
NZ (1) NZ566012A (enExample)
PL (1) PL1912649T3 (enExample)
PT (1) PT1912649E (enExample)
RS (1) RS52606B (enExample)
SI (1) SI1912649T1 (enExample)
TW (1) TWI385168B (enExample)
UA (1) UA95911C2 (enExample)
WO (1) WO2007014934A2 (enExample)
ZA (1) ZA200801106B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JP5246715B2 (ja) 2009-01-27 2013-07-24 独立行政法人科学技術振興機構 蛋白質架橋阻害剤およびその用途
CN104254527B (zh) 2012-04-27 2017-05-31 詹森药业有限公司 抗菌的喹啉衍生物
AU2013254670B2 (en) 2012-04-27 2017-03-30 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
CA3016068C (en) * 2016-03-07 2024-02-27 The Global Alliance For Tb Drug Development, Inc. Antibacterial compounds and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018326A1 (en) * 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
DK2301544T3 (da) 2002-07-25 2013-01-02 Janssen Pharmaceutica Nv Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer
WO2005070924A1 (en) * 2004-01-23 2005-08-04 Janssen Pharmaceutica N.V. Substituted quinolines and their use as mycobacterial inhibitors
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents

Similar Documents

Publication Publication Date Title
JP2009503024A5 (enExample)
HRP20131116T1 (hr) Derivati kinolina kao antibakterijska sredstva
JP2009503025A5 (enExample)
JP2006504658A5 (enExample)
CA2566544A1 (en) Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
JP2016516043A5 (enExample)
JP2008500992A5 (enExample)
JP2016506962A5 (enExample)
JP2014511892A5 (enExample)
AR040673A1 (es) Inhibidores micobacterianos, composicion farmaceutica y proceso de preparacion del compuesto
JP2014506907A5 (enExample)
JP2009523760A5 (enExample)
JP2009516697A5 (enExample)
JP2007513915A5 (enExample)
JP2011527677A5 (enExample)
JP2013537198A5 (enExample)
JP2010511667A5 (enExample)
CA3081423A1 (en) Antibacterial compounds
HRP20140206T1 (hr) Derivati kinolina kao antibakterijska sredstva
JP2009503021A5 (enExample)
JP2010511671A5 (enExample)
AU2008228941B2 (en) Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria
JP2008546824A5 (enExample)
ME01245B (me) Antibakterijski hinolinski derivati
JP2009502869A5 (enExample)